Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI)
Launched by UNIVERSITY OF MIAMI · Aug 16, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether practicing mindfulness breathing exercises can improve the overall health and quality of life for people living with spinal cord injuries (SCI). The study aims to see if these simple mindfulness techniques can help individuals feel better physically and emotionally.
To participate, adults aged 18 to 70 who have a spinal cord injury at specific levels (between C5 and T10) can apply. Participants must be able to understand the study and give their consent, and they should be in good health without any serious medical issues. Unfortunately, those taking certain medications that affect heart responses or pregnant women will not be eligible. If selected, participants can expect to engage in mindfulness exercises and share their experiences, contributing to valuable research on how these practices might enhance life for those with spinal cord injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult males and females aged 18-70 who are living with spinal cord injury
- • C5 to the T10 levels
- • Self-reported American Spinal Cord Injury Association (ASIA) Impairment Scale (AIS) A-D
- • Eligible participants must be able to understand and provide consent, be in good health operationalized as free from acute treatable illness, pressure injury, and cardiovascular disease.
- Exclusion Criteria:
- • Participants taking medications that alter chronotropic and pressor responses will be excluded.
- • Pregnant women will not be eligible to participate
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Patients applied
Trial Officials
Eduard Tiozzo, PhD
Principal Investigator
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported